Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear
NCT ID: NCT01015768
Last Updated: 2020-09-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2009-10-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations
NCT00381446
Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function
NCT00560898
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact Lenses
NCT00382681
Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers
NCT01484938
A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution
NCT05565937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test eye
Uses ReNu Multiplus as multipurpose soaking solution
ReNu Multiplus multipurpose disinfecting solution
A new lens (PureVision) soaked 6 hours to overnight in ReNu Multiplus
Control
A new lens (PureVision) is soaked for 2 hours in non-preserved saline
Control
A new lens (PureVision) is soaked for two hours in non-preserved saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ReNu Multiplus multipurpose disinfecting solution
A new lens (PureVision) soaked 6 hours to overnight in ReNu Multiplus
Control
A new lens (PureVision) is soaked for two hours in non-preserved saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understand your rights as a research subject and give written informed consent by signing the Informed Consent Form, Subject Bill of Rights, and Patient Authorization for Use and Release of Health and Research Study Information (HIPAA form).
* Be likely to finish the entire study, understand the study instructions, and be willing to follow the instructions.
* Contact lens prescription between +4.00 D to -9.00 D (spherical equivalent).
* Best correctable visual acuity of at least 20/40 in each eye.
* Willing to de-adapt (do not wear) from habitual contact lenses for a period of at least two days prior to eligibility visit and at least two days prior to the testing day.
* Possess a functional spectacle (eyeglass) prescription to allow adequate vision during the de-adaptation and barrier function determination periods.
* No known allergies, which may interfere with contact lens wear.
* No known systemic (pertaining to general health) disease, or need for medication that may interfere with contact lens wear (i.e. antihistamines, beta-blockers, steroids).
Exclusion Criteria
* Clinically significant corneal swelling (greater than grade 3 or 4 on a 0-4 scale), corneal blood vessel growth (vascularization), corneal staining, bulbar redness, tarsal redness, or any other abnormality of the cornea that may cause unsafe contact lens wear.
* Any active ocular infection.
* Prior corneal refractive surgery (i.e., LASIK, PRK, etc).
* Have used medications within 24 hours of study entry or have an ongoing need to use ocular medication.
* Are taking part in any other study or have taken part in a study within the last 14 days
* Have a medical condition that your study eye doctor thinks may make it not appropriate for you to participate in this study.
* Are pregnant, or anticipate becoming pregnant during the course of this study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern California College of Optometry at Marshall B. Ketchum University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jerry R. Paugh, OD, PhD
Professor, Associate Dean or Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jerry R Paugh, OD, PhD
Role: STUDY_DIRECTOR
Southern California College of Optometry at Marshall B. Ketchum University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern California Colege of Optometry
Fullerton, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.